US Patent Issued to PEPTRON on May 12 for "Pharmaceutical composition for treating levodopa-induced dyskinesia or for suppressing progression thereof" (South Korean Inventor)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,947, issued on May 12, was assigned to PEPTRON INC. (Daejeon, South Korea).

"Pharmaceutical composition for treating levodopa-induced dyskinesia or for suppressing progression thereof" was invented by Ho Il Choi (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A GLP-1 receptor agonist has effects of reducing serious side effects due to long-term use of levodopa when administered in combination with levodopa, and also effects of alleviating or improving abnormal involuntary movements (AIMs) caused by levodopa. A method for prevention or treatment of levodopa-induced dyskinesia according to an embodiment of the present disclosure in...